Tag: Mohamad Mohty
MaaT Pharma doses first patient in HERACLES phase 2 trial of MaaT013
MaaT Pharma,a French oncology company, said that it has dosed the first patient in the HERACLES phase 2 trial of MaaT013, a microbiome restoration candidate, in ... Read More